HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit
LOS ANGELES, Dec. 19, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Humacyte, Inc. (“Humacyte” or the “Company”) HUMA. Class Period: May 10, 2024 – October 17, 2024Lead Plaintiff Deadline: January 17, 2025 If you wish to ...










